Asia-Pacific Diabetes Care Devices Market - Growth, Trends and Forecasts (2017 - 2022)

The Asia-Pacific diabetes care devices market has been estimated at USD XX billion in 2016 and is projected to reach USD XX billion by 2021, at a CAGR of around X% during the forecast period from 2016 to 2021. Diabetes is a chronic metabolic disease characterized by high blood sugar, wherein the body is either not able to produce insulin (type-1 diabetes) or is not able to utilize the generated insulin (type-2 diabetes).

Patients with diabetes typically experience frequent urination (polyuria), increased thirst (polydipsia) and increased hunger (polyphagia). If diabetes is not controlled, it can lead to serious health complications including heart diseases, kidney diseases, stroke, amputations of the legs and feet, blindness and early death.

Asia-Pacific Diabetes Care Devices Market-Market Dynamics

The Asia-Pacific diabetes care devices market is majorly driven by the rise in the number of people with diabetes, complexities in alternative diabetes therapy and strong encouragement from the governments. However, lack of reimbursement policies and high costs associated with the diagnosis and treatment of diabetes are hindering the growth of the market. The market is growing due to the increased awareness of glucose monitoring devices and insulin delivery devices among the population. However, capitalization on patents is a major challenge faced by the market players.

The Asia-Pacific diabetes care devices market has been segmented into glucose monitoring devices (blood glucose meters, blood glucose test strips, lancing devices, continuous glucose monitoring devices); and insulin delivery devices (insulin pump, insulin syringe, and insulin pen).

The market has been geographically segmented into Australia & New Zealand, China, India, Japan and South Korea, with India and China holding the majority of the market share. Australia is also one of the dominant markets for diabetes care devices.

Some of the key players in the market are:

Arkray, Inc.


Boehringer Ingelheim GmbH

Eli Lilly

LifeScan, Inc.

Medtronic, Inc.

Key Deliverables in the Study

Market analysis for the Asia-Pacific diabetes care devices market, with region-specific assessments and competition analysis on a regional scale.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their market share.

Identification and analysis of the macro and micro factors that affect the Asia-Pacific diabetes care devices market on a regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.

Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.

1. Introduction

1.1 Study Deliverables

1.2 Market Definition

1.3 Sizing Units

1.4 Base Currency

1.5 Review and Forecast Period Years

1.6 General Study Assumptions

2. Research Methodology

2.1 Introduction

2.2 Analysis Methodology

2.3 Econometric Forecast Model

2.4 Research Assumptions

3. Executive Summary

4. Key Inferences

5. Market Characterization

5.1 Current Market Scenario

5.2 Market Overview

5.3 Drivers, Restraints, Opportunities, and Challenges (DROC) Analysis

5.3.1 Market Drivers Rise in Number of People with Diabetes Complexities in Alternative Diabetes Therapy Government Initiatives

5.3.2 Market Restraints Lack of Reimbursement Policies High Costs Associated to the Diagnosis and Treatment of Diabetes

5.3.3 Market Challenges Capitalization on Patents

5.3.4 Market Opportunities Increased Awareness on Diabetes Care Devices

5.4 Diabetes Care Devices Market Segmentation

5.4.1 By Product Glucose Monitoring Devices Blood Glucose Meters Blood Glucose Test Strips Lancing Devices Continuous Glucose Monitoring Devices Insulin Delivery Devices Insulin Pump Insulin Syringe Insulin Pen

5.4.2 By Geography Asia-Pacific Australia & New Zealand China India Japan South Korea

6. Industry Analysis

6.1 Key Trends and Developments

6.2 Investment Analysis

6.3 PorterFive Forces

6.3.1 Bargaining Power of Suppliers

6.3.2 Bargaining Power of Consumers

6.3.3 Threat of New Entrants

6.3.4 Threat of Substitute Products and Services

6.3.5 Competitive Rivalry within the Industry

7. Competitive Landscape

7.1 Key Market Players

7.1.1 LifeScan, Inc. LifeScan, Inc. - Business Overview LifeScan, Inc. - Product and Services Portfolio LifeScan, Inc. - Deals Landscape LifeScan, Inc. - SWOT Analysis

7.1.2 Arkray, Inc.

7.1.3 Eli Lilly

7.1.4 Medtronic, Inc.

7.1.5 Boehringer Ingelheim GmbH

7.1.6 Bayer

7.1.7 Others

7.2 Merger and Acquisition Analysis

7.3 New Product Launches

7.4 Agreements, Collaborations & Partnerships

8. Analyst Outlook for Investment Opportunities

9. Future Outlook of the Market

Content are not available

Choose License Type